The Patent Finder

Pierre Fabre Medicament

Also on record
Records under this name other than the patents Pierre Fabre Medicament holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 57 patents it holds.

Back to Pierre Fabre Medicament

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,766,959ANTI-C10ORF54 Antibodies and Uses Thereof
now held by Igenica, Inc.
In force
 · High confidence
In forceHigh confidence
US 12,312,336Inhibitors of Raf Kinases
In force
 · High confidence
In forceHigh confidence
US 12,569,496Treatment of Cancer with a Raf Inhibitor
In force
 · Low confidence
In forceLow confidence
US 12,209,129Anti-Met Fab-Fc for the Treatment of a Tumor And/Or Metastasis
In force
 · High confidence
In forceHigh confidence
US 12,692,248Solid State Forms of (S)-N-(3-(2-(((R)-1-Hydroxypropan-2-YL)AMINO)-6-Morpholinopyridin-4-YL)-4-Methylphenyl)-3-(2,2,2-Trifluoroethyl)PYRROLIDINE-1-Carboxamide and Salts Thereof
In force
 · High confidence
In forceHigh confidence
US 10,028,948Chromone Derivative as a Dopamine D3 Receptor Antagonist for Its Use for the Treatment of Autism Spectrum Disorder
Lapsed on the fee record
Ended Jul 24, 2026 · Medium confidence
Lapsed on the fee recordEnded Jul 24, 2026Medium confidence
US 8,945,871Novel Anti-Igf-Ir Antibodies and Uses Thereof
Term ended
Term ended Jul 21, 2026 · High confidence
Term endedTerm ended Jul 21, 2026High confidence
US 9,061,015Stable Solid Dispersion of a Derivative of Vinca Alkaloid and Process for Manufacturing It
Term ended
Term ended Jul 18, 2026 · High confidence
Term endedTerm ended Jul 18, 2026High confidence
US 11,340,233A New Universal Method to Capture and Analyze Adcs for Characterization of Drug Distribution and the Drug-To-Antibody Ratio in Biological Samples
Lapsed on the fee record
Ended May 24, 2026 · High confidence
Lapsed on the fee recordEnded May 24, 2026High confidence
US 8,697,064Nitrogenated Derivatives of Pancratistatin
Lapsed on the fee record
Ended Apr 15, 2026 · High confidence
Lapsed on the fee recordEnded Apr 15, 2026High confidence
10 of 244 records shown.
Pro members see all 244.
Pro members: see all 244 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited